Brian Newman - May 31, 2025 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP, Chief Financial Officer
Signature
/s/ Brian Newman
Stock symbol
CVS
Transactions as of
May 31, 2025
Transactions value $
$1,399,978
Form type
4
Date filed
6/3/2025, 04:35 PM
Previous filing
May 14, 2025
Next filing
Jul 2, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Newman Brian EVP, Chief Financial Officer ONE CVS DRIVE, WOONSOCKET /s/ Brian Newman 2025-06-03 0001788049

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock (RSUs) Award $1.4M +21.9K $64.04 21.9K May 31, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Award $0 +94.8K $0.00 94.8K May 31, 2025 Common Stock 94.8K $64.04 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 5/31/2026.
F2 Option becomes exercisable in four equal annual installments, commencing 5/31/2026.